Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia

Frederick A Kweh1, Jennifer L Miller, Carlos R Sulsona

  • 1Department of Pediatrics, College of Medicine, University of Florida, Gainesville, Florida.

Insights

In Prader-Willi syndrome (PWS), total ghrelin levels are higher in early nutritional phases, even in young infants before hyperphagia. This suggests high ghrelin may not directly cause hyperphagia in PWS.

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatrics

Background:

  • Elevated circulating total ghrelin is known in older Prader-Willi syndrome (PWS) patients.
  • Hyperghrelinemia in young PWS children is debated.
  • Nutritional phases, not just age, may better reflect hormone changes in PWS.

Purpose of the Study:

  • To compare total serum ghrelin levels in PWS children across nutritional phases.
  • To compare ghrelin levels in PWS patients (5 weeks to 21 years) with controls.
  • To investigate ghrelin levels in PWS versus early-onset morbid obesity (EMO) and sibling controls (SibC).

Main Methods:

  • A 12-year longitudinal study measured fasting serum total ghrelin.
  • Included 60 PWS subjects, 39 EMO subjects, and 95 SibC.
  • Analyzed ghrelin levels by PWS nutritional phase (1a, 1b, 2a, 2b, 3).

Main Results:

  • Total ghrelin levels were significantly higher in earlier PWS nutritional phases (P < 0.001).
  • Young PWS infants showed significantly higher ghrelin levels than sibling controls (P = 0.009).
  • Nutritional phase is an independent prognostic factor for ghrelin levels in PWS.

Conclusions:

  • Circulating ghrelin is elevated in young PWS children before hyperphagia onset.
  • Elevated ghrelin occurs during the early phase of poor appetite and feeding in PWS.
  • High ghrelin levels are unlikely to be the direct cause of hyperphagic nutritional phases in PWS.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.2K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.7K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
14
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
19